Skip to content
Skip to content

Donanemab

Donanemab

Donanemab (Kisunla): A Promising Treatment for Alzheimer's Disease

Donanemab Image

It also known by its brand name Kisunla. Donanemab is a monoclonal antibody used for the treatment of Alzheimer’s disease. It slow down the decline in memory, thinking, and daily functioning associated with Alzheimer’s. Here are some key points about Donanemab:

Mechanism of Action of Donanemab

The monoclonal antibody targets amyloid plaques in the brain, which are thought to contribute to Alzheimer’s symptoms. By helping the body remove these plaques, also, it slows the progression of the disease.

FDA Approval

Donanemab received FDA approval on July 2, 2024, as a treatment for adults with early symptomatic Alzheimer’s disease (including those with mild cognitive impairment) and confirmed amyloid pathology.

Clinical Trial Results

In the TRAILBLAZER-ALZ 2 clinical trial, it is significantly slowed Alzheimer’s disease progression by more than 20% at 76 weeks. Patients in earlier stages of the disease showed the most significant improvements.

Common Side Effects of Donanemab

Headache and swelling in brain areas (with or without small spots of bleeding) occurred in at least 10% of patients.

Serious Side Effects

Serious allergic reactions (swelling of face, difficulty breathing, hives) and infusion-related reactions (sweating, headache, nausea, chest pain) may occur.

Also, it represents a promising advancement in Alzheimer’s treatment, and its approval provides hope for patients and their families.

Categories

Archives

You May Also Like

    The Science Behind Stable Mixtures Emulsifying agents are the unsung heroes in many products we use daily—from creamy...
Understanding Pharmaceutical Excipients in Tablet Formulations When you take a tablet for a headache or a chronic condition, you’re likely...
  messenger RNA Vaccines: How They Work, Benefits & OPRA Exam Guide mRNA vaccines represent a groundbreaking shift in vaccine...

You cannot copy content of this page

Discover more from PETC

Subscribe now to keep reading and get access to the full archive.

Continue reading

Open chat
1
Scan the code
Hello
Please let me know how Can we help you?